Peter Stout

2 papers in the library · 60 citations · publishing 2002-2003

Papers

Sort Most recent Most cited

Comparison and Evaluation of DRI® Methamphetamine, DRI Ecstasy, Abuscreen® ONLINE Amphetamine, and a Modified Abuscreen ONLINE Amphetamine Screening Immunoassays for the Detection of Amphetamine (AMP), Methamphetamine (MTH), 3,4-Methylenedioxyamphetamine (MDA) and 3,4-Methylenedioxymethamphetamine (MDMA) in Human Urine*

Journal of Analytical Toxicology July 1, 2003 Peter Stout, K. L. Klette, Russell Wiegand 21 citations

The performances of four immunoassays (DRI amphetamines, DRI ecstasy, Abuscreen ONLINE amphetamines, and a modified Abuscreen ONLINE amphetamines) were evaluated for control failure rates, sensitivity, and specificity for amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA). The two DRI reagents and the ONLINE reagents were...

DOI: 10.1093/jat/27.5.265 Full text MDMA Ecstasy Reagent Methamphetamine +3

LC-MS Analysis of Human Urine Specimens for 2-Oxo-3-Hydroxy LSD: Method Validation for Potential Interferants and Stability Study of 2-Oxo-3-Hydroxy LSD Under Various Storage Conditions

Journal of Analytical Toxicology May 1, 2002 K. L. Klette, C. K. Horn, Peter Stout et al. 39 citations

2-Oxo-3-hydroxy lysergic acid diethylamide (O-H-LSD), a major LSD metabolite, has previously been demonstrated to be a superior marker for identifying LSD use compared with the parent drug, LSD. Specifically, O-H-LSD analyzed using liquid chromatography-mass spectrometry has been reported to be present in urine at concentrations 16 to 43 times greater than LSD. To further support forensic...

DOI: 10.1093/jat/26.4.193 Lysergic acid diethylamide Urine Metabolite Hallucinogen +2